Osteofos 35 Tablet
By Osteofos
Rx
4 Tablet in a Strip
Composition
Alendronic Acid(35mg)
Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
Expires on or after
March, 2027
When it comes to the safety of using Osteofos 35 Tablet in patients with liver disease, the available information indicates that it is likely safe to do so. From the limited data, it appears that adjusting the dose of Osteofos 35 Tablet may not be necessary for patients with liver issues. However, it is always advisable to consult with your doctor before starting any new medication, including Osteofos 35 Tablet, especially if you have liver disease. Your doctor can provide personalized guidance based on your specific health needs and condition.
Osteofos 35 Tablet requires caution in severe kidney disease. Dosage may need adjustment in such cases. Consult your doctor. No dosage adjustment needed for mild to moderate kidney disease.
It's safe to consume alcohol with Osteofos 35 Tablet.
Osteofos 35 Tablet may cause side effects that could impact driving ability. While not common, it may cause dizziness, severe muscle and joint pain, bone pain, or eye issues that could affect driving capability.
Osteofos 35 Tablet is considered unsafe during pregnancy. Animal studies indicate potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Consult your doctor before using.
Osteofos 35 Tablet is considered safe during breastfeeding. Limited data indicates no significant risk to the baby. Monitor the baby's blood calcium levels in the initial two months if using this medication.
Habit Forming | No |
Chemical Class | Bisphosphonate Derivative |
Therapeutic Class | PAIN ANALGESICS |
Action Class | Bone resorption inhibitor -Bisphosphonates |
₹170.92
Inclusive of all taxes
Content verified by
Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024